EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alder BioPharmaceuticals's enterprise value is $1,579.07 Mil.
Alder BioPharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 was $0.00 Mil. Therefore, Alder BioPharmaceuticals's EV-to-Revenue for today is .
The historical rank and industry rank for Alder BioPharmaceuticals's EV-to-Revenue or its related term are showing as below:
ALDR's EV-to-Revenue is not ranked *
in the Biotechnology industry.
Industry Median: 8.18 * Ranked among companies with meaningful EV-to-Revenue only.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Alder BioPharmaceuticals's EV-to-Revenue
For the Biotechnology subindustry, Alder BioPharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alder BioPharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alder BioPharmaceuticals's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Alder BioPharmaceuticals's EV-to-Revenue falls into.
Alder BioPharmaceuticals's current Enterprise Value is $1,579.07 Mil.
Alder BioPharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alder BioPharmaceuticals's share price for today is $18.88.
Alder BioPharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alder BioPharmaceuticals EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Alder BioPharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Alder BioPharmaceuticals (Alder BioPharmaceuticals) Business Description
Alder BioPharmaceuticals is a biotechnology company that seeks to discover, develop, and commercialize therapeutic antibodies. The company's antibody platform seeks to maximize efficacy, as well as speed of onset and durability of therapeutic response. Alder's product pipeline addresses diseases where patients have limited medical options or where current medical options may not meet the needs of a substantial number of patients. The company operates in two geographic regions: the United States and Australia. The vast majority of the Alder's assets are located in the United States, where the vast majority of its revenue is also generated.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALDR has been successfully added to your 